FDA Inspection 1020250 — Gyrus ACMI, Inc.
The FDA completed an inspection of Gyrus ACMI, Inc. on July 27, 2017 in Brooklyn Park, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 27, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Brooklyn Park, MN (United States)
Additional Details
Postmarket Audit Inspections